Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin‐A, prostate‐specific antigen, and insulin‐like growth factor‐1 in advanced prostate cancer patients
暂无分享,去创建一个
L. Dogliotti | A. Berruti | A. Mosca | A. Angeli | G. Gorzegno | R. Tarabuzzi | M. Torta | M. Mari | Dario Fontana